- $8.79bn
- $10.35bn
- $6.96bn
- 85
- 32
- 78
- 70
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,639 | 5,767 | 7,339 | 6,564 | 6,956 |
Cost of Revenue | |||||
Gross Profit | 653 | 666 | 806 | 828 | 977 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,277 | 5,710 | 7,108 | 6,221 | 6,578 |
Operating Profit | 362 | 57 | 231 | 343 | 378 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 268 | -14 | 146 | 284 | -166 |
Provision for Income Taxes | |||||
Net Income After Taxes | 209 | -42 | 35 | 192 | -261 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 202 | -63 | 27 | 190 | -265 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 202 | -63 | 27 | 196 | -265 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.34 | 0.948 | 0.51 | 1.29 | -0.899 |
Dividends per Share |